Retraction of: British Journal of Cancer (2008) 99, 1493–1501; doi:10.1038/sj.bjc.6604727
After a thorough investigation, we have recently concluded that key results contributed by the first author cannot be reproduced. As the senior and corresponding author, I have therefore decided to retract this paper.
The co-author has been informed, and agrees with this decision. I emphasise that there is no doubt whatsoever about her contribution.
I sincerely apologise for the inconvenience this may have caused to readers of this journal.
Dr Ed Roos
Division of Cell Biology
The Netherlands Cancer Institute
Change history
29 March 2012
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Author information
Authors and Affiliations
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6604727
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Meijer, J., Ogink, J. & Roos, E. Retraction Note: Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo . Br J Cancer 104, 227 (2011). https://doi.org/10.1038/sj.bjc.6606002
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6606002
This article is cited by
-
Validation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments
Molecular Therapy - Nucleic Acids (2016)
